AAAAAA
Results:
1-14
|
Results: 14
Authors:
Kanabrocki, EL
George, M
Hermida, RC
Messmore, HL
Ryan, MD
Ayala, DE
Hoppensteadt, DA
Fareed, J
Bremner, FW
Third, JLHC
Shirazi, P
Nemchausky, BA
Citation: El. Kanabrocki et al., Day-night variations in blood levels of nitric oxide, T-TFPI, and E-selectin, CL APPL T-H, 7(4), 2001, pp. 339-345
Authors:
Fareed, J
Hoppensteadt, DA
Bacher, P
Messmore, HL
Citation: J. Fareed et al., Antithrombin agents: The new class of antithrombotic drugs, EVIDENCE-BASED MANAGEMENT OF THE ACUTE CORONARY SYNDROME, 2001, pp. 131-146
Authors:
Iqbal, O
Demir, AM
Hoppensteadt, DA
Wehrmacher, WH
Messmore, HL
Fareed, J
Citation: O. Iqbal et al., Thrombolytic therapy in acute coronary syndrome, EVIDENCE-BASED MANAGEMENT OF THE ACUTE CORONARY SYNDROME, 2001, pp. 147-166
Authors:
Wallis, DE
Lewis, BE
Messmore, HL
Pifarre, R
Walenga, JM
Citation: De. Wallis et al., Inadequacy of current prevention strategies for heparin-induced thrombocytopenia (vol 5, pg S16, 1999), CL APPL T-H, 6(2), 2000, pp. 114-114
Authors:
Walenga, JM
Jeske, WP
Messmore, HL
Citation: Jm. Walenga et al., Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia, J THROMB TH, 10, 2000, pp. S13-S20
Authors:
Ahmad, S
Jeske, WP
Walenga, JM
Hoppensteadt, DA
Wood, JJ
Herbert, JM
Messmore, HL
Fareed, J
Citation: S. Ahmad et al., Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodies, CL APPL T-H, 5(4), 1999, pp. 259-266
Authors:
Messmore, HL
Kundur, R
Wehrmacher, W
Scanlon, P
Citation: Hl. Messmore et al., Anticoagulant therapy of pregnant patients with prosthetic heart valves: Rationale for a clinical trial of low molecular weight heparin, CL APPL T-H, 5(2), 1999, pp. 73-77
Authors:
Kanabrocki, EL
Sothern, RB
Messmore, HL
Roitman-Johnson, B
McCormick, JB
Dawson, S
Bremner, FW
Third, JLHC
Nemchausky, BA
Shirazi, P
Scheving, LE
Citation: El. Kanabrocki et al., Circadian interrelationships among levels of plasma fibrinogen, blood platelets, and serum interleukin-6, CL APPL T-H, 5(1), 1999, pp. 37-42
Authors:
Messmore, HL
Citation: Hl. Messmore, Heparin-induced thrombocytopenia: Historical review, CL APPL T-H, 5, 1999, pp. S2-S6
Authors:
Wallis, DE
Lewis, BE
Messmore, HL
Pifarre, R
Walenga, JM
Citation: De. Wallis et al., Inadequacy of current prevention strategies for heparin-induced thrombocytopenia, CL APPL T-H, 5, 1999, pp. S16-S20
Authors:
Fareed, J
Walenga, JM
Hoppensteadt, DA
Jeske, WP
Ahmad, S
Lietz, H
McKenna, R
Messmore, HL
Haas, S
Citation: J. Fareed et al., Soluble adhesion molecules in the HIT syndrome: Pathophysiologic role and therapeutic modulation, CL APPL T-H, 5, 1999, pp. S38-S44
Authors:
Fareed, J
Messmore, HL
Citation: J. Fareed et Hl. Messmore, Clopidogrel, a new ADP-receptor antagonist: Clinical development - Preface, SEM THROMB, 25, 1999, pp. I-II
Authors:
Walenga, JM
Messmore, HL
Fareed, H
Citation: Jm. Walenga et al., Heparin-induced thrombocytopenia - Preface, SEM THROMB, 25, 1999, pp. 1-1
Authors:
Fareed, J
Walenga, JM
Hoppensteadt, DA
Jeske, WP
Lietz, H
Ahmad, S
Callas, D
Messmore, HL
Haas, S
Citation: J. Fareed et al., Selectins in the HIT syndrome: Pathophysiologic role and therapeutic modulation, SEM THROMB, 25, 1999, pp. 37-42
Risultati:
1-14
|